Aevice Health Announces the Appointment of David Van Sickle, Former CEO of Propeller Health, as the Board Advisor
Singapore, 15 September 2022 – Aevice Health, a MedTech company developing novel wearables to enable remote management of chronic respiratory diseases, is pleased to announce the appointment of David Van Sickle, PhD, as Strategic Advisor.
Van Sickle, who served as the co-founder and former CEO of Propeller Health, has over 15 years of experience in digital health. As Aevice Health continues to transform the landscape of home management of chronic respiratory diseases such as Asthma and COPD, he will assist the team in developing its US commercialization strategy. Van Sickle will also support the company’s efforts to build clinical evidence for its remote monitoring solutions.
Aevice Health’s flagship device, the AeviceMD, is a wearable stethoscope that allows people to easily record their lung sounds and share them with their physicians. Additionally, the device analyzes the acquired sounds for key respiratory symptoms such as wheezing. From earlier studies done, the company found that clinicians who remotely examine how their patients’ lungs are doing can potentially reduce number of in person visits required to achieve the same clinical outcomes.
“I am thrilled to announce the appointment of David as Strategic Advisor,” said Adrian Ang, Aevice Health CEO. “David’s experience and expertise will be instrumental in helping Aevice Health excel in the US market and beyond. He brought Propeller Health to the global stage and revolutionized the way asthma and COPD are managed. I look forward to his guidance and believe he will serve as a similar catalyst to the growth of Aevice Health.”
While at Propeller Health, a digital health company focused on asthma and COPD medication management, the company secured notable partnerships with many leading pharmaceutical companies, health plans and provider systems. To date, Propeller Health’s connected inhalers have been used by more than 140,000 patients in 16 countries worldwide.
Van Sickle led Propeller Health through the 2019 acquisition of the company by ResMed (NYSE: RMD) and continued to run the company as a standalone business until 2021, when he became an Entrepreneur in Residence (EIR) at the San Diego-based medical equipment manufacturer. He was recently appointed Non-Executive Director by Closed Loop Medicine.
“In the US we now have appropriate coding, coverage, and reimbursement to support physicians who remotely monitor their patients with chronic respiratory disease,” said David Van Sickle. “The new wearables from Aevice Health allow easy, accurate, and reliable remote auscultation of lung sounds and enable more informed management of asthma and COPD at home and in the community. I look forward to working with the team to help them bring their wearable sensors to market in the US next year.”
This announcement comes at a momentous time for Aevice Health as the company doubles down on its strategy to scale in its key markets. The company has recently announced its participation in major accelerators in the US and APAC, including the Cedars-Sinai Accelerator and MedTech Innovator APAC. The Cedars-Sinai Accelerator is a 3 month-program that helps position companies for launch in the US market and MedTech Innovator is the largest accelerator for MedTech companies connecting participants with leading players in the MedTech industry.
 Propeller Health Fact Sheet (February 2022)
About Aevice Health
Aevice Health Pte Ltd is a MedTech company at the forefront of addressing chronic respiratory disease, one of the generation’s biggest healthcare challenges.
The company’s non-invasive wearable devices enable the early detection of cardiopulmonary abnormalities remotely and in real-time so that patients can receive fast and targeted care from the ease of their homes. Clinicians can also gain insights into their patients’ health and track their responses to treatment plans easily from the Aevice analytical platform.
In Aevice Health, our mission is to drive medical innovations that transform healthcare, improve outcomes and empower lives. More information about the company can be found at www.aevice.com.
For media enquiries, please contact:
Aevice Health Pte Ltd